Arthur Lesk is a Professor of Biochemistry and Molecular Biology at Pennsylvania State University since 2003. Previously, he held roles including faculty member at the clinical school of the University of Cambridge (1990–2003), group leader at the European Molecular Biology Laboratory (1987–1990), and professor of chemistry at Fairleigh Dickinson University (1971–1987). He earned a B.A. from Harvard University (1961), Ph.D. from Princeton University (1966), and M.Sc. from the University of Cambridge (1999). His research focuses on bioinformatics, genomics, protein structure, and molecular biology. He has authored 189 scientific articles, 10 books, and has an h-index of 61. Notable works include Protein Science (2021) and Introduction to Bioinformatics (2019). Lesk chairs CODATA’s Biological Macromolecules Task Group and is a Fellow of the AAAS and Royal Society of Biology. He maintains active teaching and research roles, delivering lectures globally. His contributions include advancing protein structure databases and computational methods for molecular biology. Lesk is a Life Member of Clare Hall, Cambridge, and has held visiting positions at universities in New Zealand, Australia, and Europe.
Dr. Sander J. Wezenberg is an Associate Professor at the Leiden Institute of Chemistry, Leiden University, where he leads an independent research group focused on developing stimuli-responsive molecular receptors and self-assembling materials. He was appointed Assistant Professor at the University of Groningen in 2017 and moved to Leiden University in 2019 to establish his research group, where he was promoted to Associate Professor in 2022. Dr. Wezenberg's educational background includes: Master's degree in Chemistry at the University of Nijmegen, conducting research in Prof. Roeland Nolte's group PhD in Supramolecular Chemistry at the Institute of Chemical Research of Catalonia (ICIQ) under Prof. Arjan Kleij (2011) Postdoctoral fellow with Prof. François Diederich at ETH Zurich Postdoctoral work with Prof. Ben Feringa at the University of Groningen His research focuses on using interdisciplinary approaches combining synthetic organic chemistry, supramolecular chemistry, and photochemistry to develop systems that can study and manipulate biological processes. Key research areas include: Photodynamic control of anion binding and lipid bilayer membrane transport Creation of polymeric and self-assembled materials with switchable functions Development of new diagnostic tools and therapeutic agents to improve human health Dr. Wezenberg's recent publications demonstrate strong trends in photoresponsive molecular systems for controlling anion transport and membrane properties. His work bridges chemistry, materials science, and biological applications, with particular emphasis on light-switchable molecular receptors and their applications in biological systems. Scientific awards and recognition: ERC Starting Grant (2018) Veni Grant from NWO (2014) Vidi Grant from NWO (2018) Member of the Young Academy of Europe (2020) Dr. Wezenberg actively mentors PhD and Master's students, with current advisees including Nol Duindam, Sabine Langens, Sofiia Emashova, Lin Xu, Dimitris Piperoudis, and Josien de Graaf. His research is supported by multiple funding sources including Leiden University, the European Research Council, the Dutch Research Council, and the China Scholarship Council. The Wezenberg Research Group is based at the Gorlaeus Laboratories in the new Gorlaeus Building at Leiden University, where they maintain a highly collaborative research environment focused on molecular switches, anion recognition, and dynamic supramolecular systems.
Henry Liang, Ph.D., is a Professor in the Department of Cell Physiology and Molecular Biophysics at Texas Tech University Health Sciences Center (TTUHSC), with adjunct appointments in Chemical Engineering and Chemistry at Texas Tech University. His lab focuses on bridging biology with synthetic systems through membrane biophysics and bioengineering. Research Interests: Dr. Liang's work spans membrane protein reconstitution, nanodisc technology, antimicrobial nanoparticles, blood-brain barrier targeting, and immunotherapy platforms. Key areas include: Design of synthetic proteomembranes for protein function studies Development of environmentally responsive nanoantibiotics Nanoparticle-based theranostic systems for cancer Light-driven energy transduction in biohybrid materials Publication Trends: His 15 most recent articles (2011-2023) demonstrate consistent focus on nanotechnology solutions for biomedical challenges, with evolving emphasis on antimicrobial nanostructures (35%), membrane protein platforms (30%), cancer nanomedicine (20%), and sustainable nanomaterials (15%). Methodological strengths include polymer synthesis, X-ray scattering, and biomimetic system design. Training: The Liang Lab actively recruits graduate students and postdoctoral researchers for projects in membrane biophysics and bioengineering. Current research infrastructure includes capabilities for synchrotron small-angle X-ray scattering, molecular dynamics simulations, and nanomaterial characterization.
Sharon Rozovsky is a Professor in the Department of Chemistry and Biochemistry at the University of Delaware's College of Arts & Sciences, where she leads research on oxidative stress response mechanisms and protein quality control pathways. Her work bridges biochemistry, chemical biology, and structural biology with direct implications for understanding neurodegenerative diseases and viral pathogenesis. Her academic foundation includes a B.S. from Tel Aviv University (1994) and a Ph.D. from Columbia University (2000), establishing her expertise in protein dynamics and redox biochemistry. These credentials underpin her innovative approaches to studying cellular stress responses. Rozovsky's research program centers on selenoproteins—proteins containing the rare amino acid selenocysteine—and their critical roles in endoplasmic reticulum (ER) stress resolution. She investigates how membrane-bound selenoproteins like Selenoprotein S and K regulate the ER-associated degradation (ERAD) pathway, with recent work revealing their surprising autoproteolytic activity and involvement in SARS-CoV-2 replication. Her lab pioneers chemical tools including expressed protein ligation and advanced 77Se NMR spectroscopy to characterize these systems at molecular resolution. Analysis of her 2021-2025 publications shows dominant themes in selenoprotein structure-function relationships, ER stress mechanisms, and viral interactions, alongside methodological innovations in cryo-EM grid technology and NMR. This body of work demonstrates consistent focus on redox biochemistry with expanding applications in virology and structural biology. No major scientific awards or fellowships were explicitly documented in the available materials, though her research impact is evident through high-impact publications and methodological contributions. She directs the active Rozovsky Research Group, mentoring graduate students and postdoctoral researchers in biochemical and biophysical techniques. Her laboratory operations are supported by competitive funding including an NSF CAREER award (2011) focused on selenoprotein reactivity, reflecting sustained recognition of her innovative research program.
Associate Professor Colin Jackson is affiliated with the Research School of Chemistry at the Australian National University College of Physical & Mathematical Sciences . His research spans enzyme engineering, synthetic biology, and protein evolution, with a focus on directed evolution approaches for biocatalysis and molecular biophysics. Former CSIRO and Weizmann Institute researcher Key projects: plastic degradation enzymes, viral protease inhibitors, noncanonical amino acid incorporation His work leverages ancestral sequence reconstruction and machine learning to explore protein sequence spaces, with notable outputs in fitness landscape analysis and biocatalytic applications . Recent publications highlight advancements in: Plastic biodegradation enzyme engineering Antiviral peptide design targeting SARS-CoV-2 Fluorinated noncanonical amino acids for protein studies Marine bacterial transport proteins Organophosphate resistance mechanisms While no formal awards are listed in this data, his research portfolio demonstrates strong industry and biomedical applications through: ANU Researcher Portal publications Collaborative projects with international institutions 50+ funded projects including gene therapy platforms and food waste solutions
Michael Krisinger is an Associate Professor of Teaching in the Department of Biochemistry & Molecular Biology at the University of British Columbia . He began his teaching career in 2010, transitioning to full-time in 2013. He lectures Biochemistry 202 (Introductory Medical Biochemistry) and Biochemistry 303 (Molecular Biochemistry) while serving as a tutor in the Faculty of Medicine's Case Based Learning program. Krisinger co-developed the department's two-course summer program for international students and mentors postdoctoral fellows in teaching. He also manages the department's CANVAS digital learning platform. Krisinger's research focuses on the molecular mechanisms of coagulation and complement system regulation , particularly their evolutionary relationship and functional interplay. His work has explored thrombin's role in complement activation, polyphosphate-mediated complement suppression, and nanoparticle surface interactions with proteolytic cascades. He previously co-supervised graduate students at UBC's Centre for Blood Research before prioritizing education. Publications highlight his expertise in protease-substrate dynamics , lipoprotein-phospholipid interactions , and hemostasis-immunity crosstalk . He remains engaged in public science through community environmental initiatives and local outreach activities.
Prof. Paul Wright is a Professor of Chemistry at the University of St Andrews, leading the Physical Chemistry Teaching program. He holds a PhD from the University of Cambridge and has held roles at Shell R&D, the Royal Institution, and St Andrews since 1994. His research focuses on nanoporous solids, including zeolites and MOFs, with applications in catalysis and carbon capture. He has pioneered methods for synthesizing novel materials and pioneered synchrotron-based structural analysis techniques. Awards include the RSC/SCI Barrer Prize and ICI Readership. He supervises PhD students in advanced materials and catalysis, and teaches courses in thermodynamics, kinetics, and heterogeneous catalysis. Education: PhD in Chemistry, University of Cambridge (1986) Research Interests: Prof. Wright’s work spans five core areas: (1) Designing zeolite templates for novel structures, (2) Developing MOFs with unique properties, (3) Optimizing zeolites/MOFs for CO₂ adsorption, (4) Investigating catalytic applications of microporous solids, and (5) Advanced structural characterization using synchrotron techniques. Recent breakthroughs include understanding ‘sentinel’ cations in zeolites for selective adsorption and developing tandem catalysts combining MOFs with metal nanoparticles. Publications Trends: His articles emphasize structure-property relationships in porous materials, with 2011–2015 papers focusing on scandium-based frameworks, CO₂ capture mechanisms, and catalytic performance of SAPOs and MOFs. Collaborations with institutions like Edinburgh University and European projects highlight applied energy solutions. Awards: RSC/SCI Barrer Prize (1999) ICI Readership (2002–2004) Teaching & Grants: Leads Physical Chemistry courses at all levels, including a 5th-year Masters course in Heterogeneous Catalysis. Active in placement student monitoring via CH4441. Grants include European projects on mixed matrix membranes for CO₂ separation. Labs/Teams: Heads a research group investigating nanoporous solids, collaborating with institutions like Aberdeen University on synchrotron-based catalysis studies.
Prof. Casper Hoogenraad is a full professor in Molecular Neuroscience at the Department of Cell Biology, Faculty of Science, Utrecht University. His research focuses on understanding how intracellular protein trafficking underlies neuronal development and function, with particular emphasis on the microtubule cytoskeleton, synaptic cargo trafficking, and synaptic plasticity. He leads an active research group within Utrecht University's Cell Biology department and collaborates extensively with other neuroscience research groups. Education: PhD, Erasmus University Rotterdam (1996-2001) Postdoc, Massachusetts Institute of Technology (2002-2005) Hoogenraad's research spans three main themes: cytoskeleton dynamics during neurodevelopment and synaptic plasticity, motor proteins and adaptors as regulators of synaptic transport, and psychiatric and neurologic disease disorders linked to intracellular transport. His work combines genetics, biochemistry, molecular, and cellular biology methods in in vitro (neuron cultures), ex vivo (brain slices), and in vivo (mice) systems, along with advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging, and photo-activated localization microscopy (PALM). Analysis of Hoogenraad's recent publications reveals a strong focus on microtubule organization, neuronal polarity, and the molecular mechanisms underlying synaptic function and dysfunction. His work frequently explores how disruptions in intracellular transport contribute to neurological disorders including Alzheimer's disease, schizophrenia, and autism spectrum disorders, with particular attention to the relationship between cytoskeletal organization and cargo transport in neuronal compartments. Scientific Awards and Memberships: ZonMW-VIDI (2004) European Young Investigators (EURYI) award (2005) NWO-ALW VICI (2011) ERC Consolidator grants (2013) FENS-Kavli Network of Excellence (2014) European Molecular Biology Organization (EMBO) (2015) Young Academy of Europe (YAE) (2015) IBRO Kemali Prize (2016) Hoogenraad leads a research group studying neuronal development and function, with a particular focus on how intracellular transport mechanisms contribute to both normal brain function and neurological disorders. His laboratory employs a multidisciplinary approach combining molecular, cellular, and systems neuroscience techniques to investigate the molecular basis of neuronal polarity, synaptic plasticity, and the pathogenesis of neurological disorders. He has secured significant research funding through prestigious grants including ERC Consolidator grants. The Hoogenraad lab operates within the Cell Biology department at Utrecht University, collaborating with other research groups focusing on cellular dynamics, biophysics, and neurobiology. The lab utilizes advanced microscopy techniques including immunofluorescent confocal microscopy, high-resolution live cell imaging (spinning disc microscopy and total internal reflection fluorescence microscopy), and quantitative analysis using advanced high-resolution microscopy (photo-activated localization microscopy). Current lab technicians include Phebe Wulf and Bart de Haan.
Sarah Lummis is a Professor in the Department of Biochemistry at the University of Cambridge. Her research focuses on understanding the structure-function relationships of Cys-loop ligand-gated ion channels (pLGICs), which are critical for neurotransmission and targets for pharmaceuticals. Her work addresses how structural features of these receptors influence their function and drug interactions. Research interests include ion channel biology, molecular pharmacology, and structural biology. Key publications investigate residues affecting receptor activity in 5-HT3 receptors, glycine receptors, and the prokaryotic channel ELIC. Her studies contribute to drug development for neurological disorders like epilepsy and Alzheimer's disease. Contact: sl120sec@bioc.cam.ac.uk | Group accepts interns, students, and researchers. Located at the Hopkins Building, Downing Site, Cambridge.
Eric W. Schmidt is a Distinguished Professor of Medicinal Chemistry at the University of Utah, with adjunct appointments in Biological Sciences and Chemistry. His research focuses on natural products chemistry, biosynthesis, synthetic biology, and pharmaceutical applications of marine animal microbiomes. University of California, San Diego (BS, PhD) Research areas include: Biosynthesis in animals and their microbiomes Synthetic biology approaches to chemical engineering Drug design from marine natural products Metagenomic analysis of symbiotic relationships Neuroactive compound discovery Antibiotic development against resistant pathogens His lab has pioneered methods for: Biosynthetic gene cluster identification Heterologous expression in E. coli Enzymatic modification of peptides Chemical analysis of marine invertebrates Recent publications highlight discoveries in: Marine animal chemical defense mechanisms Evolution of biosynthetic pathways Antibiotic resistance profiling Ionic channel-targeting compounds Peptide macrocyclization techniques Lipid-polyketide biosynthesis continuum Email: ews1@utah.edu Honors include: Distinguished Professor recognition
Jeff S Abramson is a Professor of Physiology in the David Geffen School of Medicine at the University of California Los Angeles (UCLA). His research focuses on the structural and functional characterization of membrane transport proteins, particularly sugar transporters and mitochondrial channels. He maintains an active laboratory investigating the molecular mechanisms of cellular transport processes. Dr. Abramson's primary research interests center on membrane transport proteins, with particular emphasis on sugar symporters and voltage-dependent anion channels (VDACs). His work combines structural biology, biophysics, and biochemistry to understand the molecular mechanisms of transport, including conformational changes during transport cycles, substrate recognition, and regulation by membrane potential. His research has significant implications for understanding metabolic disorders, mitochondrial function, and potential therapeutic targets. Analysis of Dr. Abramson's publication record reveals a consistent focus on membrane protein structure-function relationships over the past two decades. His work demonstrates expertise in X-ray crystallography, cryo-electron microscopy, and functional assays to characterize transport proteins. Recent publications show increasing emphasis on mitochondrial biology, particularly VDAC structure and function, while maintaining his longstanding interest in sugar transport mechanisms. His research bridges fundamental biophysical principles with potential biomedical applications in metabolic diseases. Dr. Abramson has been awarded multiple NIH grants supporting his research, including the R35GM135175 grant titled 'Deciphering molecular details of cellular sugar transport and their roles in disease' (2020-2024), R01GM124783 'Functional and structural studies of unique pathogenic transporters involved in glycobiology' (2017-2021), and R01GM078844 'Structural and functional characterization of sugar transporters in health and disease' (2006-2020). As Principal Investigator, Dr. Abramson has mentored numerous graduate students and postdoctoral researchers. His laboratory has made significant contributions to understanding the structure-function relationships of membrane transport proteins through collaborations with researchers across multiple disciplines. The lab utilizes advanced techniques including X-ray crystallography, cryo-EM, electrophysiology, and computational modeling to address fundamental questions about membrane protein mechanisms. Dr. Abramson's laboratory is part of UCLA's broader research ecosystem focused on structural biology and membrane protein research. His work intersects with several research centers at UCLA including those focused on metabolic diseases and structural biology. The lab maintains active collaborations with researchers specializing in biophysics, computational modeling, and disease mechanisms to translate basic findings into potential biomedical applications.
Associate Professor Judy Hart is a materials scientist at the School of Materials Science & Engineering, UNSW Sydney , specializing in the development of semiconducting materials for renewable energy applications. Her work integrates computational (DFT) and experimental approaches to understand composition-property relationships in systems like solid solutions , heterostructures , and doped materials for photocatalysis and solar cells . She leads projects funded by ARC Discovery and Linkage grants , including work on photo-electro-catalysis systems and stabilizing ceramic materials . Education: PhD in Materials Engineering (Monash University, 2007), BEng (Materials) (Monash, 2002) Professional Experience: Senior Lecturer (UNSW, 2017–), Lecturer (UNSW, 2013–2017), University of Bristol (2007–2012) Research Interests Her research focuses on designing materials for renewable energy , particularly photoelectrochemical water splitting and organic oxidation reactions . Key areas include Density Functional Theory (DFT) , defect engineering , band gap tuning , and nanostructured materials . She investigates ferroelectric polarization effects , metal oxide heterostructures , and stability of battery components , with applications in hydrogen production , CO2 conversion , and advanced battery materials . Scientific Awards Ramsay Memorial Fellowship (University of Bristol, 2007–2009) Teaching Contributions She is co-author of the 1st Australian & New Zealand edition of "Materials Science and Engineering: An Introduction" , and teaches courses on computational materials science , corrosion-resistant surfaces , mechanical behavior of metals , and materials design .
Ronald Hedden is a Professor of Practice in the Department of Chemical and Biological Engineering at Rensselaer Polytechnic Institute (RPI), where he focuses on innovations in undergraduate education and polymer science. Previously, he served as an Associate Professor at Texas Tech University (2009–2017). His current research emphasizes Virtual Reality (VR) integration into chemical engineering education, including the development of a Virtual Chemical Plant (VCP) simulation to provide safe, cost-effective access to process equipment. His research interests span chemical engineering, polymer science, soft materials, and nanomaterials. Notable projects include applying VR for teaching process safety and dynamics, as well as exploring nanocomposite materials and membrane technologies. He also investigates polymer rheology and structure-property relationships using advanced characterization techniques like NMR and SANS. Hedden teaches both core chemical engineering courses and interdisciplinary engineering subjects. His work bridges academic research and practical applications, with contributions to biofuel refining, asphalt modification, and nanoparticle incorporation in polymers. While no specific awards are listed, his extensive publication record highlights impactful contributions to materials science and educational technology. His advisory work involves student projects on VR simulations and materials engineering. He collaborates on initiatives like the VCP platform, aimed at advancing safety training and process control education. Hedden’s career reflects a commitment to both cutting-edge research and transformative pedagogy in engineering education.
Lan Guan is a Professor at Texas Tech University Health Sciences Center in the Department of Cell Physiology and Molecular Biophysics within the School of Medicine. He also serves as Co-Director of the Center for Membrane Protein Research. His research focuses on membrane proteins, which constitute approximately 30% of all eukaryotic proteins and play crucial roles in many aspects of cell function. Dr. Guan's research seeks to understand the mechanisms of solute transport and lay the foundation for advances in disease treatment and human health. He employs an integrated approach including cryo-EM single-particle analysis, X-ray crystallography, ligand binding, molecular dynamics simulations, thermodynamics, genetic engineering, novel amphiphiles, and many other biochemical & biophysical analyses. His current research focuses on cation-coupled bacterial and human transporters. Dr. Guan is currently supported by an NIGMS MIRA R35 Award (2024). His publication record demonstrates expertise in membrane protein structure and function, particularly with melibiose transporters (MelB) and their mechanisms. His work spans structural biology, biochemistry, and biophysics, with significant contributions to understanding membrane transport mechanisms. His research has led to important insights into membrane protein structure-function relationships, particularly in sugar transporters. Dr. Guan's work has implications for understanding fundamental biological processes and potential therapeutic applications related to membrane transport. NIGMS MIRA R35 Award 2024 Dr. Guan actively collaborates with researchers across disciplines and institutions, as evidenced by his extensive publication record with numerous co-authors. His work bridges structural biology, biochemistry, and biophysics to advance our understanding of membrane protein function. He is affiliated with the Center for Membrane Protein Research, where he contributes to advancing methodologies for studying these challenging but critically important biological molecules. His work on novel amphiphiles and detergent design has helped overcome technical barriers in membrane protein research.
Associate Professor LAM Yulin is affiliated with the National University of Singapore (NUS), specializing in bioorganic and medicinal chemistry with a focus on green synthesis methodologies. His research interests include developing anti-cancer, anti-inflammatory, and neurological agents, alongside creating recyclable catalysts for sustainable organic transformations. He holds a Ph.D. (1992) and B.Sc. (1987) from NUS, with prior research fellowships at the Institute of Molecular and Cell Biology (1994–1996) and The Scripps Research Institute (1992–1994). Teaching contributions include courses such as CM2122 Organic Chemistry, CM3225 Biomolecules, and CM5224 Emerging Concepts in Drug Discovery. His research highlights include synthesizing chondroitin sulfate analogs for molecular recognition via surface-enhanced Raman scattering (SERS) and developing fluorous boronic acid catalysts for amide bond formation under eco-friendly conditions. Research focuses on glycosaminoglycan structure-function relationships, novel mycobacterial inhibitors, and autophagy-inducing agents. His work bridges organic synthesis with biomedical applications, emphasizing sustainability and translational potential.
